Business volume increased over the year-earlier period with growing sales of bio line and fashion Line, and rising customers¡¯ trust in adult stem cell line.Net loss posting increased due to a rise in miscellaneous losses and interest cost, excessive sales and admin expenses and cost price due to the improvement of cost structure.Capability in bio business improved by selling cosmetics business, signing with BioLife Stem Cell Corp., USA for stem cell technology transfer, and merging with RNL Sammi.Co., Ltd. Stable growth will continue as stem cell storage service and stem cell technology transfer are active while gaining patents for cell cure medicines from the 31 European countries.Profitability improvement will be impeded by sales commission payment while stem cell line grows.New financial sources will be secured as the stem cell production facility is establishment in Texas to store stem cells and provide services.
Headquarters
1596-7, BONGCHEON 7-DONG, GWANAK-GU, SEOUL
Seoul; Seoul;
Postal Code: 151835
Contact Details: Purchase the RNL Bio Co., Ltd. report to view the information.
Website: http://www.rnl.co.kr
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service